selected publications
-
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
Cell.
2023
Academic Article
GET IT
Times cited: 2 -
Signaling-to-chromatin pathways in the immune system.
Immunological reviews.
2021
Information Resource
GET IT
Times cited: 2 -
Histone H3.3 phosphorylation amplifies stimulation-induced transcription.
Nature.
2020
Academic Article
GET IT
Times cited: 83 - Gene regulatory networks STARR-ing B cells. Nature immunology. 2020 Article GET IT
-
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2.
Epigenetics & chromatin.
2019
Academic Article
GET IT
Times cited: 43 - Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer. Oncogene. 2019 Academic Article GET IT
-
Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity.
Epigenetics.
2017
Academic Article
GET IT
Times cited: 9 -
MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation.
Human molecular genetics.
2017
Academic Article
GET IT
Times cited: 19 -
MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Advances in experimental medicine and biology.
2017
Article
GET IT
Times cited: 7 -
Circadian cycle-dependent MeCP2 and brain chromatin changes.
PloS one.
2015
Academic Article
GET IT
Times cited: 21 -
MeCP2: the long trip from a chromatin protein to neurological disorders.
Trends in molecular medicine.
2014
Information Resource
GET IT
Times cited: 61 -
An increase in MECP2 dosage impairs neural tube formation.
Neurobiology of disease.
2014
Academic Article
GET IT
Times cited: 15 -
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
Oncogene.
2013
Academic Article
GET IT
Times cited: 114 -
Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.
Nucleic acids research.
2013
Academic Article
GET IT
Times cited: 23 -
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
The Journal of clinical investigation.
2012
Academic Article
GET IT
Times cited: 387